Iron Metabolic Biomarkers and the Mortality Risk in the General Population: A Nationwide Population-Based Cohort Study——supplemental material

Table S1. Quartiles according to baseline SF and TSAT levels in the general population and stratified by diabetes    Table S2. Sensitivity analysis: HRs (95% CIs) for mortality according to quartiles of serum ferritin among individuals, after excluding participants whose outcome occurred during the first 3 years of follow-up in NHANES III and NHANES 1999-2010    Table S3. HRs (95% CIs) for mortality according to quartiles of serum ferritin among women in NHANES III and NHANES 1999-2010    Table S4. HRs (95% CIs) for mortality according to quartiles of serum ferritin among men in NHANES III and NHANES 1999-2010    Table S5. HRs (95% CIs) for mortality according to quartiles of serum ferritin among participants with 3 years of follow-up    Table S6. HRs (95% CIs) for mortality according to quartiles of serum ferritin among participants with 10 years of follow-up    Table S7. HR and 95% CI for all-cause and cause-specific mortality according to Serum ferritin stratified by DM    Table S8. Sensitivity analysis: HRs (95% CIs) for mortality according to quartiles of Transferrin saturation among individuals, after excluding participants whose outcome occurred during the first 3 years of follow-up in NHANES III and NHANES 1999-2010    Table S9. HRs (95% CIs) for mortality according to quartiles of transferrin saturation among women in NHANES III and NHANES 1999-2010    Table S10. HRs (95% CIs) for mortality according to quartiles of transferrin saturation among men in NHANES III and NHANES 1999-2010    Table S11. HRs (95% CIs) for mortality according to quartiles of transferrin saturation among participants with 3 years of follow-up    Table S12. HRs (95% CIs) for mortality according to quartiles of transferrin saturation among participants with 10 years of follow-up    Table S13. HR and 95% CI for all-cause and cause-specific mortality according to Transferrin saturation stratified by DM    Figure S1 Flow chart of the screening process for the selection of eligible participants in NHANESIII and NHANES 1999-2010    Figure S2. Association relationships between SF and risk of all-cause and cause-specific mortality stratified by sex.    Figure S3. Association relationships between TSAT and risk of all-cause and cause-specific mortality stratified by sex.